Blood typing has become a routine test item of clinical blood transfusion department and clinical laboratory, which includes ABO blood group, Rh blood group, and cross-matching of blood test.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Qiagen reported after the close of the market on Wednesday that its third quarter revenues grew 11 percent year over year as growth in non-COVID-related product groups tempered an expected decline in COVID-19-related product sales.

Peng Yang, global vice president of Danaher and president of Danaher China, recently said in an exclusive interview with a reporter from 21st Century Business Herald during the J.P.Morgan Global Healthcare Conference, Shanghai Forum, "We believe China Will Become the World's Largest IVD Market ."

CTK Biotech said on Tuesday that its OnSite COVID-19 Ag Self Test has been CE marked.

Pacific Biosciences said after the close of the market on Tuesday that its third quarter revenues rose 83 percent, driven by growth in sequencing instruments and consumables.

Thermo Fisher Scientific said on Monday that it has acquired Belgium-based PharmaFluidics, the developer of the μPAC range of microchip-based chromatography columns.

Bruker reported after the close of the market Monday that revenues in the third quarter rose 19 percent year over year.

Hologic reported after the close of the market on Monday that its fiscal fourth quarter revenues fell 2 percent year over year, driven by a drop in molecular diagnostic and COVID-19 assay sales.

Some of the neurological symptoms associated with menopause are similar to early signs of dementia. The ability of MHT to alleviate such symptoms in some women has led scientists to question whether a link exists between specific hormone levels and dementia.

The US Food and Drug Administration on Thursday said it has granted Emergency Use Authorization for Detect's over-the-counter, at-home SARS-CoV-2 test.

A few days ago, EUROIMMUN (PerkinElmer) formally completed the acquisition of British diagnostic company Immunodiagnostic Systems (IDS). In the future, IDS, as a new member of the PerkinElmer Group, will cooperate closely with EUROIMMUN in the fields of R&D, production, and sales.